New study shows advance in CAR T-cell therapy eliminates severe side effects

    Source: Xinhua| 2019-04-23 18:39:02|Editor: xuxin
    Video PlayerClose

    LOS ANGELES, April 23 (Xinhua) -- An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, according to a new study of the University of Southern California (USC).

    "This is a major improvement. We've made a new CAR molecule that is just as efficient at killing cancer cells, but it works more slowly and with less toxicity," said Si-Yi Chen of the USC Norris Comprehensive Cancer Center, and senior author of the study appearing online Monday in Nature Medicine.

    This improved version of CAR T therapy produced no serious side effects in 25 patients who had lymphoma that recurred after previous treatments. Although the study was designed to look at safety, not effectiveness, six out of 11 participants receiving a commonly used dose went into complete remission.

    CAR T therapy involves harvesting immune cells called T cells from a patient's blood and then modifying them in the lab to produce special structures called chimeric antigen receptors (CAR) on their surface.

    The altered T cells are reinfused into the patient, where the cells' new receptors enable them to recognize and latch onto cancer cells, killing them.

    Approved by the U.S. Food and Drug Administration less than two years ago, CAR T is a literal lifesaver for some people with leukemia and lymphoma, bringing lasting remissions to those on the brink of death.

    The downside is that the treatment often causes severe side effects -- some of them life-threatening -- which must be managed by experienced specialists.

    In this revised version, researchers tweaked the sequence and shape of the CAR molecules. As a result, the CAR T cells kill cancer cells but produce fewer cytokines and proliferate more slowly, giving the patient's body more time to clear cytokines in the blood.

    "The improved CAR T cells proliferated and differentiated into memory cells in the patients, thus producing a potent and long-lasting anti-tumor effect without causing toxicities," Chen said.

    The research team's next step is to perform a multi-center phase II to test safety and effectiveness in a larger group of patients.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011100001380019091
    主站蜘蛛池模板: 午夜性色一区二区三区不卡视频| 在线观看网站禁入口不用下载| 亚洲国产品综合人成综合网站| 国产免费久久精品丫丫| 一本色道久久88亚洲精品综合| 最近免费中文字幕视频高清在线看| 四影虎影ww4hu32海外网页版| 伊人一伊人色综合网| 好男人看的视频2018免费| 久久天天躁狠狠躁夜夜躁2020| 毛片a级毛片免费播放100| 嘟嘟嘟www在线观看免费高清| 国产三级小视频在线观看| 天堂岛最新在线免费看电影| 久久丫精品国产亚洲av| 欧美午夜在线播放| 免费在线成人网| 色综合一区二区三区| 国产精品亚洲а∨无码播放不卡 | 狠狠综合久久久久尤物丿| 国产乱子伦农村XXXX| 亚洲欧美18v中文字幕高清| 夜夜高潮夜夜爽夜夜爱爱一区| 中文字幕一区二区区免| 日韩国产在线观看| 亚洲欧美一区二区三区| 精品无码久久久久久久久| 国产浮力第一影院| 99免费观看视频| 性色av一区二区三区| 久久久精品午夜免费不卡| 欧美aⅴ菲菲影视城视频| 亚洲精品无码专区在线| 精品久久久中文字幕| 国产一级淫片视频免费看| 丁香六月综合网| 国产精品国产亚洲精品看不卡| 伊人久久综在合线亚洲91| 豆奶视频高清在线下载| 国产特级毛片aaaaaa毛片| 97国产在线视频|